Pfizer, AstraZeneca Jabs Effective Against Delta Variant

Reuters reports:

COVID-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90% against hospitalisation from the Delta coronavirus variant, a new analysis by Public Health England (PHE) showed on Monday.

PHE said that the Pfizer/Biontech COVID-19 vaccine was 96% effective against hospitalisation from the Delta variant after two doses, while Oxford/AstraZeneca’s offered 92% protection against hospitalisation by Delta.

Read the full article.

Very very good news from Public Health England: the vaccine works on the Delta/Indian variant

Pfizer 96% effective against hospitalisation after 2 doses

AstraZeneca 92% effective against hospitalisation after 2 doses

This is a lot better than experts had previously feared

— Alex Wickham (@alexwickham) June 14, 2021